Calvert Research

Commercial success in building the next generation of therapeutic drugs begins with identifying and acquiring the best potential drug candidates. Once licensed, Calvert Research rapidly and efficiently advances those assets to preclinical or clinical proof of concept, and delivers a valuable therapeutic to a development partner or acquirer.
Our proven record of development and commercial success, driven by in-house expertise at each of these stages allows Calvert Research to leverage an integrated approach from the earliest phase of preclinical drug development. The result is a first-rate portfolio of therapeutic assets poised for commercial success and ready for acquisition.

